<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7805975</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3416</journal-id>
<journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id>
<journal-id journal-id-type="iso-abbrev">Diabetes Care</journal-id>
<journal-title-group>
<journal-title>Diabetes care</journal-title>
</journal-title-group>
<issn pub-type="ppub">0149-5992</issn>
<issn pub-type="epub">1935-5548</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30377186</article-id>
<article-id pub-id-type="pmc">6354912</article-id>
<article-id pub-id-type="doi">10.2337/dc18-1060</article-id>
<article-id pub-id-type="manuscript">EMS80372</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cognitive, neurological and behavioral features in adults with <italic>KCNJ11</italic> neonatal diabetes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Bowman</surname>
<given-names>Pamela</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Day</surname>
<given-names>Jacob</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torrens</surname>
<given-names>Lorna</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shepherd</surname>
<given-names>Maggie H</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knight</surname>
<given-names>Bridget A</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ford</surname>
<given-names>Tamsin J</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Flanagan</surname>
<given-names>Sarah E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chakera</surname>
<given-names>Ali</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hattersley</surname>
<given-names>Andrew T</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeman</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>University of Exeter Medical School, Exeter, UK</aff>
<aff id="A2"><label>2</label>Exeter NIHR Clinical Research Facility, Exeter, UK</aff>
<aff id="A3"><label>3</label>Kent Neuropsychology Service, Kent and Medway NHS and Social Care Partnership Trust, UK</aff>
<author-notes>
<corresp id="CR1">Corresponding author, Dr Pamela Bowman, Medical Research, Level 3 RILD Building, Barrack Road, Exeter, EX25DW, Telephone 01392408325, <email>P.Bowman@exeter.ac.uk</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P38">
<bold>Conflicts of interest disclosures</bold>
</p>
<p id="P39">None to declare.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>42</volume>
<issue>2</issue>
<fpage>215</fpage>
<lpage>224</lpage>
<!--elocation-id from pubmed: 10.2337/dc18-1060-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Central nervous system (CNS) features in children with permanent neonatal diabetes (PNDM) due to <italic>KCNJ11</italic> mutations have a major impact on affected families. Sulfonylurea therapy achieves outstanding metabolic control, but only partial improvement in CNS features. The effects of <italic>KCNJ11</italic> mutations on the adult brain and their functional impact are not well described. We aimed to characterise the CNS features in adults with <italic>KCNJ11</italic> PNDM, compared to adults with <italic>INS</italic> PNDM.</p>
</sec>
<sec id="S2">
<title>Research Design and Methods</title>
<p id="P2">Adults with PNDM due to <italic>KCNJ11</italic> mutations (n=8) or <italic>INS</italic> mutations (n=4) underwent a neurological examination, and completed standardised neuropsychological tests/questionnaires about development/behavior. Four individuals in each group underwent a brain MRI scan. Test scores were converted to Z-scores using normative data, and outcomes compared between groups.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">In individuals with <italic>KCNJ11</italic> mutations, neurological examination was abnormal in 7/8; predominant features were subtle deficits in coordination/motor sequencing. All had delayed developmental milestones and/or required learning support/special schooling. Half had features and/or a clinical diagnosis of autism spectrum disorder. <italic>KCNJ11</italic> mutations were also associated with impaired attention, working memory and perceptual reasoning, and reduced IQ (median IQ <italic>KCNJ11</italic> vs <italic>INS</italic> mutations 76 vs 111, p=0.02). However, no structural brain abnormalities were noted on MRI. The severity of these features was related to the specific mutation and they were absent in individuals with <italic>INS</italic> mutations.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4"><italic>KCNJ11</italic> PNDM is associated with specific CNS features which are not due to long-standing diabetes, persist into adulthood despite sulfonylurea therapy, and represent the major burden from <italic>KCNJ11</italic> mutations.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>